thymine has been researched along with Liver Diseases in 2 studies
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "0%) had at least 1 adverse event leading to study discontinuation." | 2.90 | Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment. ( Bebeau, P; Becerra, C; Rosen, L; Rudek, MA; Saif, MW; Shepard, DR; Sun, W; Winkler, R; Yamashita, F, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saif, MW | 1 |
| Rosen, L | 1 |
| Rudek, MA | 1 |
| Sun, W | 1 |
| Shepard, DR | 1 |
| Becerra, C | 1 |
| Yamashita, F | 1 |
| Bebeau, P | 1 |
| Winkler, R | 1 |
| BEHKI, RM | 1 |
| MORGAN, WS | 1 |
1 trial available for thymine and Liver Diseases
| Article | Year |
|---|---|
Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bilirubin; Drug Administration Schedule; D | 2019 |
1 other study available for thymine and Liver Diseases
| Article | Year |
|---|---|
STUDIES ON THE PHOSPHORYLATION OF THYMIDINE IN REGENERATING RAT LIVER.
Topics: Cytosine; DNA; Fluorides; Liver Diseases; Liver Regeneration; Nucleosides; Nucleotidases; Oxidative | 1964 |